AKRO Market Cap History
Below is a table of the AKRO market cap history going back to 8/12/2019:

Date AKRO Market Cap

Also see: AKRO Shares Outstanding History
and AKRO YTD Return
AKRO Historical Market Cap:
+65.05% CAGR
AKRO Historical Market Cap: +65.05% CAGR

Mouse over chart for data details
Akero Therapeutics is a cardio-metabolic nonalcoholic steatohepatitis company. Co. is developing medicines that restore metabolic balance and improve overall health. Co.'s main product candidate, AKR-001, is an analog of fibroblast growth factor 21 (FGF21), which is an endogenously expressed hormone that regulates metabolism of lipids, carbohydrates and proteins throughout the body. FGF21 also plays a role in protecting various types of cells from various forms of stress. We show 6 historical shares outstanding datapoints in our AKRO shares outstanding history coverage, used to compute AKRO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AKRO market cap history over the course of time is important for investors interested in comparing AKRO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AKRO versus a peer is one thing; comparing AKRO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AKRO can fluctuate over the course of history. With this page we aim to empower investors researching AKRO by allowing them to research the AKRO market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AKRO:
AKRO SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Akero Therapeutics (AKRO) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AKUS Market Cap History
ALAC Market Cap History
ALEC Market Cap History
ALGR Market Cap History
ALLE Market Cap History
ALLK Market Cap History
ALLO Market Cap History
ALRS Market Cap History
ALTA Market Cap History
ALTG Market Cap History
More Miscellaneous companies »


AKRO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.